What is Oak?
Oak (oaklovesyou.com) is a telehealth platform specializing in GLP-1 weight loss medications — semaglutide and tirzepatide — with one of the highest patient satisfaction ratings in the space. Their standout feature is flat dose pricing: rather than charging different amounts for different dose tiers (which is how most GLP-1 clinics structure their pricing), Oak charges one flat monthly fee regardless of whether you're starting at a low dose or at a maintenance dose.
This matters because GLP-1 protocols typically involve dose escalation over months. With variable pricing, patients on higher doses often pay significantly more than they expected when they enrolled. Oak removes that uncertainty entirely. At $183/month for semaglutide injection and $250/month for tirzepatide injection — with a $50 first-month discount on both — Oak offers competitive pricing combined with cost predictability that most competitors don't match.
The 4.6 Trustpilot score (one of the highest in telehealth GLP-1 clinics) reflects strong patient satisfaction with outcomes, service, and delivery.
Treatments Offered by Oak
Semaglutide — Injectable & Oral
Oak offers semaglutide in both injectable and oral formats. Injectable semaglutide ($183/month) is the more bioavailable form — subcutaneous weekly injection, same format as branded Ozempic/Wegovy. Oral semaglutide ($245/month) offers a needle-free alternative with convenient daily dosing. Both formats use Oak's flat pricing model: the price stays the same regardless of your dose tier.
The $50 first-month discount applies to the injectable. Clinical evidence for injectable semaglutide: the STEP 1 trial demonstrated 14.9% average body weight reduction over 68 weeks.
Tirzepatide — Injectable
Tirzepatide at $250/month is the most potent option in Oak's formulary. The dual GIP/GLP-1 agonist outperformed semaglutide in the SURMOUNT-1 trial with a mean 22.5% body weight reduction at 72 weeks. The $50 first-month discount applies here too, and the flat pricing model means you won't see price increases as you titrate from 2.5mg to the 10mg or 15mg maintenance range.
Why Flat Pricing Matters
Most GLP-1 clinics charge more for higher doses — a common structure charges $150/month at 0.5mg but $250+/month at 2.4mg. With Oak, the price is locked at $183/month for semaglutide injection across all doses. If your protocol takes 6 months to reach maintenance dosing, you won't face a mid-protocol price jump.
Oak Pricing
Oak Protocol Pricing (2026)
Who Oak is Best For
- Patients who want price certainty throughout a GLP-1 protocol — no surprise increases as you titrate up
- Anyone comparing semaglutide options who wants competitive mid-range pricing ($183/mo is solid value)
- Patients who prefer oral semaglutide — Oak offers a supervised oral option at $245/month
- Anyone who weighs patient satisfaction scores in their provider selection — 4.6 Trustpilot is among the highest in the GLP-1 telehealth category
Who Should Look Elsewhere
- Patients who need NAD+, testosterone, or a multi-compound protocol — Oak is GLP-1 focused
- Anyone seeking the absolute lowest semaglutide entry price — Maximus ($99.99/mo intro), Tonik ($149/mo), and others are cheaper, though often with dose-tiered pricing or intro limitations
- Patients who need BPC-157, PT-141, or any peptides beyond GLP-1
Pros
- Flat dose pricing — no cost increases as you titrate up
- $50 off first month on semaglutide and tirzepatide
- 4.6 Trustpilot — among the highest patient satisfaction scores in GLP-1 telehealth
- Both injectable and oral semaglutide available
- Transparent, simple pricing structure — no hidden fees
- Physician-supervised with compounding pharmacy fulfillment
Cons
- GLP-1 only — no NAD+, testosterone, or other compounds
- Semaglutide at $183/mo isn't the cheapest option at starter doses
- No tirzepatide oral format (injection only)
- Narrower formulary than full-service clinics
Oak Patient Reviews
Oak's 4.6 Trustpilot rating reflects consistently positive patient feedback. Recurring themes in reviews include satisfaction with treatment effectiveness, responsive and helpful customer support, and smooth medication delivery. Patients frequently highlight the straightforward onboarding process and the predictability of costs over time. The high rating across a meaningful volume of reviews suggests Oak maintains consistent service quality as they scale — which is harder to achieve than simply having a few positive early reviews.
Check current reviews at Trustpilot →
Oak vs Competitors
vs Gala ($149/mo tirzepatide): Gala is cheaper for tirzepatide but only at microdose. Oak's $250/mo covers all dose tiers. If you're planning to titrate to a maintenance dose, Oak may actually cost less overall than a clinic with variable pricing.
vs Tonik ($149/mo sema, $229/mo tirz): Tonik is cheaper for both GLP-1s but has tiered pricing and also covers testosterone, NAD+, and GHK-Cu. Choose Oak for GLP-1-only simplicity and a stronger Trustpilot track record; choose Tonik if you need multi-compound coverage.
vs Maximus ($99.99/mo intro sema): Maximus intro pricing is lower but reverts to $132.99/mo after 15 weeks. Oak's $183/mo may actually be cheaper over a 12-month horizon than Maximus after the intro expires, depending on dose. Oak wins on pricing predictability; Maximus wins on first-year cost at lower doses.
See: Full semaglutide provider comparison →
Our Verdict on Oak
Oak earns a high rating for combining transparent flat-rate pricing, a genuine $50 first-month discount, and an industry-leading 4.6 Trustpilot score. For GLP-1 patients who've been burned by unexpected price increases during dose escalation at other clinics, Oak's model is a real differentiator. The pricing is mid-range rather than budget — not the cheapest option at starter doses — but for patients who expect to titrate to a maintenance dose, the flat pricing often makes Oak more cost-effective over a full protocol.
The limitation is formulary depth: Oak does GLP-1 and does it well, but nothing else. Multi-compound patients should look at Tonik, Maximus, or Marek Health.
Rating: 8.5/10 — Best for Transparent, Flat-Rate GLP-1 Pricing